The Knowledge Hub for Medical Imaging Professionals: Transforming Radiology with Structured Reporting, Data-Driven Approaches and Multicentric Research

Access breakthrough research, innovative case studies and collaborative projects advancing radiology worldwide. Dive into our activities and product updates, and learn who we are as a company and as a team.

Alt text (EN) This picture shows several doctors looking at a medical image within the program mint Lesion™

On-Site BZKF BORN Roll-Out Trainings Keep on Going

Our expert Steffen Rupp recently visited the Technical University of Munich to continue the on-site BZKF BORN Roll-Out Trainings.

As mentioned earlier this month in a press release by the Bayerisches Zentrum für Krebsforschung (BZKF), the second funding for the BORN project was launched and the project is in full swing: the templates that were previously developed at six university hospitals are now being used and tested in their clinical routine.

What does the BZKF BORN project do? The goal of the Bavaria-wide Oncological Radiology Network (BORN) is to help patients and healthcare professionals across the state. The project carries out cancer imaging examinations in a standardized manner, evaluates them systematically, and establishes the requisite framework for data collection and exchange. It thus creates a globally unique data base for diagnosing and treating cancer.

Mint Medical and Brainlab are working closely with the university hospitals and the Bayerisches Zentrum für Krebsforschung (BZKF) to establish uniform and structured reporting in oncological imaging, as well as to develop a secure IT infrastructure for the capture and exchange of data.

(Image shows anonymized demo case.)

Further information about the project is available here: www.bzkf.de/born/

Related Resources

Related Resources

How to improve reading procedures and reduce errors in clinical trials with imaging endpoints

Dr. Laura Oleaga from Hospital Clinìc de Barcelona explains how she and her team have benefitted from implementing mint Lesion™ in the face of an…

Objective, reproducible, and trustworthy data in clinical trials with imaging endpoints

Dr. Anthony Tolcher, medical oncologist and CEO of NEXT Oncology, spoke to us about objectivity as one of the biggest challenges in clinical trials…

University Hospital Jena: Study evaluated response rate and safety in patients with HCC treated with DEB-TACE using 40-µm microspheres

Researchers at the University Hospital Jena analyzed the response rate and safety of superselective drug-eluting beads transarterial chemoembolization…